A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Clinical trial NCT05171049 · TERMINATED

Trial details

NCT number: NCT05171049
Sponsor: Anthos Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism Deep Venous Thrombosis Pulmonary Embolism

Start date: 2022-05-05
Primary completion: 2026-02-04
Enrollment: 1150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.